Publications by authors named "V C-H Lui"

The canonical Hippo-YAP1 signaling pathway is crucial for liver development and regeneration, but its role in repair and regeneration of intrahepatic bile duct in biliary atresia (BA) remains largely unknown. YAP1 expression in the liver tissues of patients with BA and Rhesus rotavirus-induced experimental BA mouse models were examined using quantitative reverse transcriptase-PCR and double immunofluorescence. Mouse EpCAM-expressing cell-derived liver organoids were generated and treated with Hippo-YAP1 pathway activators (Xmu-mp-1 and TRULI) or an inhibitor (Peptide17).

View Article and Find Full Text PDF
Article Synopsis
  • Kasai portoenterostomy (KPE) is the main treatment for biliary atresia (BA), but predicting outcomes is difficult due to unreliable biomarkers.
  • Researchers analyzed liver biopsies from BA patients before and after KPE and compared them to control liver samples, focusing on gene expression changes.
  • Findings suggest that high hepatocyte expression in KPE organoids may indicate abnormal cholangiocyte development, while a transition towards more cholangiocyte features in surviving patients suggests better biliary recovery.
View Article and Find Full Text PDF

High-throughput sequencing of single-cell data can be used to rigorously evlauate cell specification and enable intricate variations between groups or conditions. Many popular existing methods for differential expression target differences in aggregate measurements (mean, median, sum) and limit their approaches to detect only global differential changes. We present a robust method for differential expression of single-cell data using a kernel-based score test, cytoKernel.

View Article and Find Full Text PDF

Purpose: We performed animal and organoid study to evaluate the anti-fibrotic effect of steroid on biliary atresia (BA) and the underlying patho-mechanism.

Methods: BA animal models were created by inoculation of mice on post-natal day 1 with rhesus rotavirus (RRV). They received either 20 µl phosphate-buffered saline (PBS) or steroid from day 21 to day 34.

View Article and Find Full Text PDF
Article Synopsis
  • - Biliary atresia (BA) is a serious liver condition affecting 1:5,000 to 1:20,000 newborns, mostly in Asia, characterized by damage to the biliary system leading to cholestasis, with its causes not fully understood but possibly linked to ciliary dysfunction and oxidative stress.
  • - Timely surgical intervention (Kasai portoenterostomy) can help restore bile flow, benefiting about 50-75% of patients, but many still face severe complications like cholangitis and liver failure, with more than half needing transplantation by age 18.
  • - Improved early diagnosis and coordinated care, along with ongoing research into disease mechanisms and therapies targeting the immune response or oxidative stress
View Article and Find Full Text PDF